Key result
Preoperative liver stiffness >12.5 kPa was associated with an 80% incidence of major adverse events compared to 25% in patients with ≤12.5 kPa following LVAD implantation.
Why the study?
Does liver stiffness measured by transient elastography predict the requirement of RVAD and major adverse events in patients with severe heart failure undergoing LVAD implantation?
Population
30 patients with severe heart failure who underwent left ventricular assist device implantation. Exclusion…
Design
Cohort
Follow-up
30 days
Authors
Loading...
May support preoperative risk stratification before LVAD; leaves open whether elastography should guide RVAD decisions.
Observational (n=30)
No
Does liver stiffness measured by transient elastography predict the requirement of RVAD and major adverse events in patients with severe heart failure undergoing LVAD implantation?
Absolute Event Rate: 80% vs 25%
p-value: p=<0.05
Liver stiffness measured by transient elastography is a useful non-invasive marker that correlates with preoperative severity and predicts the need for right ventricular assist device support and postoperative complications in patients undergoing LVAD implantation.
Nishi et al. (2014) conducted an observational in Severe heart failure (n=30). Preoperative liver stiffness >12.5 kPa vs. Preoperative liver stiffness ≤12.5 kPa was evaluated on Major adverse events (MAE) within 30 days (p=<0.05). Preoperative liver stiffness >12.5 kPa was associated with an 80% incidence of major adverse events compared to 25% in patients with ≤12.5 kPa following LVAD implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: